| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC1115 | Brasofensine Maleate | Monoamine Reuptake Inhibitor |
|
| DCC1116 | Brassilexin | Inhibitor of cyclobrassinin hydrolase, a unique enzyme from the fungal pathogen Alternaria brassicicola |
|
| DCC1117 | Brazilein | Natural small molecule isolated from dried heartwood of Caesalpinia sappan L, exhibiting multi-pharmacological activities |
|
| DCC1118 | Brd0026 | Novel multistage antimalarial inhibitor |
|
| DCC1119 | Brd0761 | Novel Inhibitor of Clostridium difficile |
|
| DCC1120 | Brd20322 | Novel potent inhibitor of spCas9, disrupting spCas9-DNA binding and exerting dose and temporal control of spCas9 in human cell lines |
|
| DCC1121 | Brd2577 | Novel HDAC inhibitor, inhibiting multiple HDAC enzymes and modulates acetylation levels in cells |
|
| DCC1122 | brd2761 | Positive control for HSPC toxicity; Inhibitor of STK33 |
|
| DCC1123 | Brd3067 | Negative control for tubastatin A |
|
| DCC1124 | Brd3316 | Novel inhibitor of parasite phenylalanyl-tRNA synthetase (PheRS) |
|
| DCC1125 | Brd3811 | Novel non-histone nuclear substrate of histone deacetylase 8 (HDAC8) |
|
| DCC1126 | Brd4 Bd1-in-4 | Novel selective BET BD1 inhibitor with preferred binding to of BRD4 BD1 |
|
| DCC1127 | Brd4 Bd2 Inhibitor N13 | Novel potent inhibitor of BRD4 BD2 |
|
| DCC1128 | Brd4 D1 Inhibitor 26 | Novel potent BRD4 D1 inhibitor with over 500-fold selectivity against BRD2 D1 and BRD4 D2 via ITC |
|
| DCC1129 | Brd4097 | Negative control in HDAC1/2/3/8 assays |
|
| DCC1130 | Brd5384 | Novel HDAC8 inhibitor |
|
| DCC1131 | Brd6897 | Novel Mitochondrial Content Inducer |
|
| DCC1132 | Brd7539 | Novel dihydroorotate dehydrogenase (DHODH) inhibitor |
|
| DCC1133 | Brd7929 | Novel multistage antimalarial inhibitor for single-dose treatment of malaria in mouse models |
|
| DCC1134 | Brd-8000 | Novel specific inhibitor of the hypomorph growth |
|
| DCC1135 | Brd9185 | Novel inhibitor of dihydroorotate dehydrogenase (DHODH), showing in vitro activity against multidrug-resistant blood-stage parasites |
|
| DCC1136 | Brd-9327 | Novel specific inhibitor of the hypomorph growth of EfpA, a largely uncharacterized, but essential efflux pump in Mtb |
|
| DCC1137 | Br-dapi Dihydrochloride | Novel water-soluble, DNA-binding photosensitizer for the eradication of both Gram-negative and Gram-positive bacteria |
|
| DCC1138 | Brl42715 | Active-site-directed inactivator of bacterial beta-lactamases |
|
| DCC1139 | Brl-52537 Hydrochloride | Highly κ/μ-selective potent κ ligand |
|
| DCC1140 | Brofaromine Hydrochloride | Reversible inhibitor of monoamine oxidase A, acting on epinephrine, norepinephrine, serotonin, and dopamine |
|
| DCC1141 | Bromantane | Inhibitor of the reuptake of both dopamine and serotonin in the brain |
|
| DCC1142 | Bromhexine | Mucolytic agent used in the treatment of respiratory disorders associated with viscid or excessive mucus. |
|
| DCC1143 | broussoflavonol C | Antitumor agent |
|
| DCC1144 | bruguiesulfurol | Novel PTP1B inhibitor |
|
